{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:47:49Z","timestamp":1761677269887,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jtct.2024.02.016","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T21:07:11Z","timestamp":1708463231000},"page":"526.e1-526.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8998-0732","authenticated-orcid":false,"given":"Rebecca","family":"Epperly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-488X","authenticated-orcid":false,"given":"Subodh","family":"Selukar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Mamcarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Qudeimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-2081","authenticated-orcid":false,"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-6706","authenticated-orcid":false,"given":"Aimee","family":"Talleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari H.","family":"Dallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-9980","authenticated-orcid":false,"given":"Brandon","family":"Triplett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.02.016_bib0001","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41409-021-01267-0","article-title":"Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS","volume":"56","author":"Sharma","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0002","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/bmt.2012.209","article-title":"Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies","volume":"48","author":"Bajwa","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0003","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/bmt.2016.360","article-title":"Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the soci\u00e9t\u00e9 Francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"52","author":"Roux","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0004","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.16441","article-title":"Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children","volume":"189","author":"Uden","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.02.016_bib0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbmt.2018.09.016","article-title":"Outcomes after second hematopoietic cell transplantation in children and young adults with relapsed acute leukemia","volume":"25","author":"Lund","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0006","article-title":"Efficacy of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia: results of a systematic review and meta-analysis","author":"Kharfan-Dabaja","year":"2022287671","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.02.016_bib0007","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbmt.2003.08.003","article-title":"Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia","volume":"9","author":"Meshinchi","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0008","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.1993.11.2.304","article-title":"Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation\u2013containing regimens","volume":"11","author":"Radich","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.02.016_bib0009","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bmt.1704645","article-title":"Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant","volume":"34","author":"Eapen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0010","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bbmt.2015.02.024","article-title":"Outcomes after second hematopoietic stem cell transplantations in pediatric patients with relapsed hematological malignancies","volume":"21","author":"Naik","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0011","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1080\/10428194.2020.1716220","article-title":"Role of a second transplantation for children with acute leukemia following posttransplantation relapse: a study by the Turkish Bone Marrow Transplantation Study Group","volume":"61","author":"Hazar","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2024.02.016_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1221782","article-title":"Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients","volume":"13","author":"Troullioud Lucas","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2024.02.016_bib0013","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12185-009-0266-9","article-title":"Survival after cord blood transplantation from unrelated donor as a second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia","volume":"89","author":"Oda","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2024.02.016_bib0014","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jtct.2021.01.025","article-title":"Feasibility and outcomes of a third allogeneic hematopoietic stem cell transplantation: a retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"27","author":"Rank","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.02.016_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41409-021-01485-6","article-title":"Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed\/refractory acute leukemia after a second transplantation","volume":"57","author":"Kobayashi","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0016","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2024.02.016_bib0017","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41409-019-0750-7","article-title":"Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution","volume":"55","author":"Mamcarz","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0018","first-page":"158","article-title":"Outcome of haploidentical peripheral blood allografts using post-transplantation cyclophosphamide compared to matched sibling and unrelated donor bone marrow allografts in pediatric patients with hematologic malignancies: a single-center analysis","volume":"28","author":"Srinivasan","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.02.016_bib0019","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/bloodadvances.2020001648","article-title":"Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults","volume":"4","author":"Symons","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.02.016_bib0020","first-page":"217","article-title":"Comparison of quality of life and outcomes between haploidentical and matched related\/unrelated donor allogeneic hematopoietic cell transplantation","volume":"28","author":"Hong","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.02.016_bib0021","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.bbmt.2017.07.014","article-title":"Major histocompatibility mismatch and donor choice for second allogeneic bone marrow transplantation","volume":"23","author":"Imus","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0022","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s00277-020-04283-0","article-title":"Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory\/relapsed acute myeloid leukemia not in remission status","volume":"99","author":"Lu","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2024.02.016_bib0023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbmt.2016.11.016","article-title":"Nonmyeloablative haploidentical bone marrow transplantation with post-transplantation cyclophosphamide for pediatric and young adult patients with high-risk hematologic malignancies","volume":"23","author":"Klein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0024","first-page":"262","article-title":"Sub-myeloablative second transplantations with haploidentical donors and post-transplant cyclophosphamide have limited anti-leukemic effects in pediatric patients","volume":"28","author":"Epperly","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.02.016_bib0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bbmt.2014.04.020","article-title":"Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia","volume":"20","author":"Srinivasan","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0026","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0027","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0028","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bjh.14965","article-title":"Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003\/2007 trial","volume":"180","author":"Kuhlen","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.02.016_bib0029","first-page":"701","article-title":"Health-related quality of life in young adult survivors of hematopoietic cell transplantation","volume":"28","author":"Rotz","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.02.016_bib0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/bmt.2010.287","article-title":"Hematopoietic stem cell transplantation in children with cancer and the risk of long-term psychological morbidity in the bereaved parents","volume":"46","author":"Jalmsell","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.02.016_bib0031","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/1049732320912410","article-title":"Falling down the rabbit hole: child and family experiences of pediatric hematopoietic stem cell transplant","volume":"30","author":"West","year":"2020","journal-title":"Qual Health Res"},{"key":"10.1016\/j.jtct.2024.02.016_bib0032","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","article-title":"Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose","volume":"89","author":"Sierra","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.02.016_bib0033","article-title":"When less is good, is none better? The prognostic and therapeutic significance of peri-transplant minimal residual disease assessment in pediatric acute lymphoblastic leukemia","volume":"6:66","author":"Lamble","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtct.2024.02.016_bib0034","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/JCO.2008.17.6065","article-title":"Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group","volume":"27","author":"Bader","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.02.016_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/hematology.2021000259","article-title":"Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics","volume":"2021","author":"Hong","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724002227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724002227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T08:04:23Z","timestamp":1727769863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724002227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2666636724002227"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.02.016","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}